GENEVA, July 2 -- ASCENTAWITS PHARMACEUTICALS, LTD. filed a patent application (CN2025/143978) for “METHOD FOR TREATING CANCER AND TUMOR PATIENTS BY COMBINING AKR1C3 ENZYME-ACTIVATED COMPOUND AND IMMUNE CHECKPOINT INHIBITOR”. With publication no. WO/2026/130539, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/664
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....